latest news releases from the newsroom
Penwest Pharmaceuticals Co.
Penwest Reports Fourth Quarter and Year End 2008 Financial Results
DANBURY, Conn., March 4, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced its financial results for the fourth quarter and full year ended December 31, 2008. Compared with the fourth quarter of 2007, revenues increased sharply, operating expenses decreased by 30% and the Company's net loss was significantly reduced to $0.07 per share.
Chelsea Therapeutics Reports Fourth Quarter and Full Year 2008 Results
CHARLOTTE, N.C., March 4, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the fourth quarter and full year 2008 and will host a conference call this morning at 11:00 AM ET to discuss these results and provide a quarterly update on the Company's development progress.
SunOpta Announces Appointment of Eric Davis as Vice President and Chief Financial Officer
TORONTO, March 4, 2009 (GLOBE NEWSWIRE) -- SunOpta Inc. (Nasdaq:STKL) (TSX:SOY) today announced the appointment of Mr. Eric Davis to the position of Vice President and Chief Financial Officer, SunOpta Inc., effective March 16, 2009. In this role Mr. Davis will report to Steve Bromley, President and Chief Executive Officer, SunOpta Inc., and assume responsibility for providing leadership and direction to the Company's financial activities including financial reporting, banking and treasury, tax, investor relations and special projects.
TASER International, Inc.
TASER International Dismissed From In-Custody Death Lawsuit
SCOTTSDALE, Ariz., March 4, 2009 (GLOBE NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), the market leader in advanced electronic control devices (ECDs), announced that the court in the in-custody death lawsuit entitled Wells, et al. v. TASER International, et al. which was filed in the United States District Court for the Eastern District of California, Fresno Division, issued an order dismissing TASER International with prejudice from this lawsuit.